Cargando…
Single-agent chemotherapy in low-risk gestational trophoblastic neoplasia
BACKGROUND: Low-risk gestational trophoblastic neoplasia could be cured in the case of appropriate management with single-agent chemotherapy. This study was carried out to compare the efficacy of single-dose methotrexate versus Actinomycin-D in low-risk gestational trophoblastic neoplasia to analyze...
Autores principales: | Mousavi Seresht, Leila, Farazestanian, Marjaneh, Yousefi, Zohreh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Babol University of Medical Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878903/ https://www.ncbi.nlm.nih.gov/pubmed/36741498 http://dx.doi.org/10.22088/cjim.14.1.108 |
Ejemplares similares
-
Effect of Combination Therapy of Methotrexate with Vitamin A in Patients with Low Risk GTN (Gestational Trophoblastic Neoplasia)
por: Ghasemian, Sedigheh, et al.
Publicado: (2018) -
Resistance to single-agent chemotherapy in low-risk gestational trophoblastic neoplasia
por: Sheikhhasani, Shahrzad, et al.
Publicado: (2023) -
Predictors of chemotherapy resistance & relapse in gestational trophoblastic neoplasia
por: Singhal, Seema, et al.
Publicado: (2020) -
A review on management of gestational trophoblastic neoplasia
por: Sharami, Seyedeh Reyhaneh Yousefi, et al.
Publicado: (2020) -
Factors Predicting Severe Myelosuppression and Its Influence on Fertility in Patients with Low-Risk Gestational Trophoblastic Neoplasia Receiving Single-Agent Methotrexate Chemotherapy
por: Tu, Xiaoyu, et al.
Publicado: (2020)